MBX
Price
$46.40
Change
+$2.49 (+5.67%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.21B
44 days until earnings call
Intraday BUY SELL Signals
WVE
Price
$6.03
Change
-$0.14 (-2.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.16B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MBX vs WVE

MBX vs WVE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MBX vs. WVE commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBX is a Buy and WVE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (MBX: $43.79 vs. WVE: $6.16)
Brand notoriety: MBX and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBX: 88% vs. WVE: 62%
Market capitalization -- MBX: $2.08B vs. WVE: $1.19B
MBX [@Biotechnology] is valued at $2.08B. WVE’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBX’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 1 green FA rating(s).

  • MBX’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 1 green, 4 red.
According to our system of comparison, MBX is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBX’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 5 bullish TA indicator(s).

  • MBX’s TA Score: 5 bullish, 5 bearish.
  • WVE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, WVE is a better buy in the short-term than MBX.

Price Growth

MBX (@Biotechnology) experienced а +12.34% price change this week, while WVE (@Biotechnology) price change was +2.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

MBX is expected to report earnings on Aug 06, 2026.

WVE is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBX($2.21B) has a higher market cap than WVE($1.16B). MBX YTD gains are higher at: 38.840 vs. WVE (-63.765). MBX has higher annual earnings (EBITDA): -98.56M vs. WVE (-187.88M). WVE has more cash in the bank: 545M vs. MBX (440M). MBX has less debt than WVE: MBX (555K) vs WVE (15.7M). WVE has higher revenues than MBX: WVE (71.8M) vs MBX (0).
MBXWVEMBX / WVE
Capitalization2.21B1.16B190%
EBITDA-98.56M-187.88M52%
Gain YTD38.840-63.765-61%
P/E Ratio3.88N/A-
Revenue071.8M-
Total Cash440M545M81%
Total Debt555K15.7M4%
FUNDAMENTALS RATINGS
WVE: Fundamental Ratings
WVE
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBXWVE
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MBX
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSMT23.100.02
+0.10%
Invesco BulletShares 2029 Muncpl Bd ETF
CPSN27.64-0.02
-0.07%
Calamos S&P 500 Structured Alt Protection ETF - November
SPUT28.19-0.05
-0.18%
Innovator Eq Prm Inc -Daily PutWrite ETF
VPLS77.32-0.16
-0.20%
Vanguard Core-Plus Bond ETF
FDNI25.76-0.48
-1.84%
First Trust Dow Jones Intl Intnt ETF

MBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBX has been loosely correlated with CNTN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MBX jumps, then CNTN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBX
1D Price
Change %
MBX100%
+1.77%
CNTN - MBX
37%
Loosely correlated
-4.93%
KOD - MBX
36%
Loosely correlated
+1.36%
SION - MBX
31%
Poorly correlated
+3.97%
WVE - MBX
31%
Poorly correlated
N/A
TGTX - MBX
30%
Poorly correlated
+2.20%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with GPCR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
N/A
GPCR - WVE
64%
Loosely correlated
+2.43%
KYMR - WVE
53%
Loosely correlated
+9.97%
FRMM - WVE
44%
Loosely correlated
+2.18%
IBIO - WVE
44%
Loosely correlated
+2.96%
OCUL - WVE
44%
Loosely correlated
+5.83%
More